...
首页> 外文期刊>Clinical and diagnostic laboratory immunology >Detection of Phenolic Glycolipid I ofMycobacterium leprae in Sera from Leprosy Patients before and after Start of Multidrug Therapy
【24h】

Detection of Phenolic Glycolipid I ofMycobacterium leprae in Sera from Leprosy Patients before and after Start of Multidrug Therapy

机译:开始多药治疗前后麻风病人血清中分枝杆菌麻风酚糖脂I的检测

获取原文
           

摘要

A total of 100 untreated new leprosy patients were recruited prospectively and examined for the presence of phenolic glycolipid I (PGL-I) antigen in their serum specimens by dot enzyme-linked immunosorbent assay (ELISA) using rabbit anti-PGL-I antiserum. The presence of circulating PGL-I antigen was closely related to the bacterial indices (BI) of the patients. The PGL-I antigen was detectable in 27 (93.1%) of 29 patients with a BI of 4.0 or above and in 15 (68.2%) of 22 patients with a BI of 3.0 to 3.9. However, none of the 37 patients with a BI of less than 1.9 had detectable PGL-I antigen by the methods used in this study. The level of PGL-I in serum declined rapidly by about 90% 1 month after the start of multidrug therapy. This study showed clearly that anti-PGL-I IgM antibodies and circulating PGL-I antigen levels reflect the bacterial loads in untreated leprosy patients. The serological parameters based on the PGL-I antigen may therefore be useful in the assessment of leprosy patients at the time of diagnosis and possibly in monitoring patients following chemotherapy.
机译:前瞻性招募了总共100名未经治疗的新麻风病人,并使用兔抗PGL-1抗血清通过斑点酶联免疫吸附测定(ELISA)检查了他们的血清标本中酚糖脂I(PGL-1)抗原的存在。循环中的PGL-1抗原的存在与患者的细菌指数(BI)密切相关。在29例BI≥4.0的患者中有27例(93.1%)可以检测到PGL-1抗原,在22例BI≥3.0至3.9的患者中有15例(68.2%)可以检测到。然而,通过本研究中使用的方法,BI小于1.9的37例患者中没有一个可检测到PGL-1抗原。在开始多药治疗后1个月,血清中PGL-1的水平迅速下降了约90%。这项研究清楚地表明,抗PGL-1 IgM抗体和循环中的PGL-1抗原水平反映了未经治疗的麻风病人的细菌负荷。因此,基于PGL-1抗原的血清学参数在诊断时可用于评估麻风病人,并可能用于监测化疗后的病人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号